Muscular Diseases: Clinical Trials

6,550 trials for Muscular Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3655 completed, 994 unknown, 771 recruiting, 320 not yet recruiting. 3249 Not applicable, 733 Phase 2, 476 Phase 3, 390 Phase 1, 266 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable3249Completed 1904, Unknown 522, Recruiting 358, Not yet recruiting 185, Terminated 91, Active not recruiting 88, Withdrawn 45, Enrolling by invitation 44, Suspended 12
Phase 2733Completed 394, Terminated 90, Unknown 81, Recruiting 70, Active not recruiting 41, Not yet recruiting 22, Withdrawn 22, Enrolling by invitation 12, Suspended 1
Phase 3476Completed 291, Unknown 55, Terminated 52, Recruiting 25, Active not recruiting 23, Withdrawn 16, Enrolling by invitation 7, Not yet recruiting 7
Phase 1390Completed 192, Recruiting 71, Unknown 41, Terminated 32, Active not recruiting 18, Not yet recruiting 15, Withdrawn 13, Enrolling by invitation 7, Suspended 1
Phase 4266Completed 154, Unknown 38, Terminated 23, Recruiting 19, Withdrawn 14, Active not recruiting 9, Not yet recruiting 6, Enrolling by invitation 3
Early Phase 178Completed 22, Unknown 17, Recruiting 15, Not yet recruiting 9, Active not recruiting 6, Terminated 3, Withdrawn 3, Suspended 2, Enrolling by invitation 1

Follow Muscular Diseases: new trials by email Literature Review of Muscular Diseases trials Research Report on Muscular Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Personalizing Veteran Pain Care: Adapting Coaching Interventions to Support Maintenance of Self-Care
Coaching - Chronic Pain, Musculoskeletal Pain
Phase 1Not yet recruitingVA Office of Research and Development302029-01-012026-03-06
Neoadjuvant Pimicotinib Combined With Surgery Versus Upfront Surgery for Diffuse Tenosynovial Giant Cell Tumor
Pimicotinib, Tumor resection surgery - Tenosynovial Giant Cell Tumor, Diffuse
Phase 2Not yet recruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine842027-10-012026-07-16
Feasibility and Acceptability of OLP-EXP in Chronic Pain
OLP-EXP, OLP, EXP - Temporomandibular Disorders (TMD)
Not applicableNot yet recruitingUniversity of Maryland, Baltimore572027-07-012026-08-25
Feasibility and Preliminary Effects of an Asynchronous Microlearning Intervention on Fibromyalgia Knowledge Among Primary Health Care Workers
Written Educational Material on Fibromyalgia, Asynchronous Microlearning Intervention on Fibromyalgia - Fibromyalgia, Fibromyalgia (FM)
Not applicableNot yet recruitingInstituto Neurociencia Del Dolor682027-06-012026-10-13
Lateral Cord Stimulation as a New Treatment for Refractory Spastic Cerebral Palsy
Lateral spinal cord surgical implant of electrodes - Cerebral Palsy, Spasticity
Not applicableNot yet recruitingJuan Carlos M. Andreani MD402027-06-012026-04-28
Focused Versus Multi-Target Trigger Point Injection for Chronic Myofascial Neck Pain
Lidocaine 1% Trigger Point Injection - Myofacial Pain Syndrome, Chronic Neck Pain
Not applicableNot yet recruitingMardin Artuklu University1002027-04-012026-10-20
A Basket Clinical Study to Assess Glycerol Tributyrate in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus)
Glycerol Tributyrate - MELAS Syndrome, Lebers Hereditory Optic Neuropathy With Extra Ocular Symptoms (LHON-Plus)
Phase 1 / Phase 2Not yet recruitingGeorge Washington University242027-03-012026-10-05
A Study to Investigate the Safety, Pharmacokinetics (PK), and Efficacy of Garetosmab in Children and Adolescents With Fibrodysplasia Ossificans Progressiva (FOP)
garetosmab - Fibrodysplasia Ossificans Progressiva, FOP
Phase 3Not yet recruitingRegeneron Pharmaceuticals182027-02-022026-10-20
Teams Engaged in Accessible Mental Health Interventions for Lupus Erythematosus and Dermatomyositis Stress
TEAM-LEADS - Lupus, Dermatomyositis, Juvenile
Not applicableNot yet recruitingDuke University252027-02-012026-05-27
Effects of Hydrogen-rich Water Consumption on Transient Fatigue During an Official Football Match.
Hydrogen-Rich Water (HRW), Placebo Water - Exercise-Induced Fatigue, Football Performance
Not applicableNot yet recruitingPalacky University302027-01-202026-10-08
Regenerative Medicine for Joint Hypermobility and Instability
Dextrose 20% Prolotherapy, Autologous Platelet-Rich Plasma, Doxycycline Hyclate Injectable (Investigational) - Ehlers-Danlos Syndrome Hypermobility Type (hEDS), Ehlers-Danlos Syndrome (EDS)
Phase 1 / Phase 2Not yet recruitingManhattan Pain Medicine, PLLC1002027-01-152026-10-06
AI and Computer Vision-Assisted Telerehabilitation in Fibromyalgia: The FibroIA 2.0 Trial
AI Combined (mobility and resistance training), AI mobility - Fibromyalgia, Fibromyalgia (FM)
Not applicableNot yet recruitingInstituto Neurociencia Del Dolor662027-01-042026-07-01
Treatment of Fibromyalgia and PTSD With Live and Inactive Vagus Nerve Stimulation With PEPC
tAN plus PEPC, sham plus PEPC - Fibromyalgia (FM), Posttraumatic Stress Disorder (PTSD)
Not applicableNot yet recruitingVA Office of Research and Development1802027-01-012026-09-29
FIBROmyalgia: Somatic Tracking and Exercise Program Study
Group exercising, Somatic tracking, General activity recommendaitons - Fibromyalgia (FM), Fibromyalgia
Not applicableNot yet recruitingUniversity of Tromso2002027-01-012025-05-13
Multimodal Therapy for Somatosensory Tinnitus
Multimodal physiotherapy for TMJ and Cervical spine, Combined Exercise Program (Aerobic + Resistance + Breathing), Tinnitus-Specific Psychological Support - Ear Noise, Tinnitus, Noise Induced
Not applicableNot yet recruitingCharles University, Czech Republic1602027-01-012026-03-12
Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)
INTENT Neural Interface System - Tetraplegia/Tetraparesis, Amyotrophic Lateral Sclerosis (ALS)
Not applicableRecruitingJohns Hopkins University52027-01-012026-10-09
A Study to Investigate Arbaclofen ER Tablets for the Treatment of Spasticity in Patients With Multiple Sclerosis
Arbaclofen, Placebo - Spasticity
Phase 3Not yet recruitingRVL Pharmaceuticals, Inc.4422027-01-012025-12-03
A Phase IIb Study of Nabiximols for Spasticity Due to Neuromyelitis Optica Spectrum Disorders
Nabiximols, Placebo - NMO Spectrum Disorder, Spasticity, Muscle
Phase 2WithdrawnMichael, Levy M.D.,Ph.D.2026-12-312025-07-16
A Study of SAT-3247 to Evaluate the Safety, Tolerability, and Efficacy in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)
forazapadin, Placebo Comparator - Facioscapulohumeral Muscular Dystrophy (FSHD)
Phase 2Not yet recruitingSatellos Bioscience, Inc.512026-12-152026-10-13
A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies
Placebo, Nerandomilast - Idiopathic Inflammatory Myopathies
Phase 3Not yet recruitingBoehringer Ingelheim2702026-12-142026-10-14

Showing 20 of 6550. Sign in to see all of them.

Narrower conditions

Fibromyalgia (1230)  ·  Muscle Spasticity (619)  ·  Temporomandibular Joint Disorders (588)  ·  Pain (518)  ·  Muscular Dystrophy, Duchenne (478)  ·  Musculoskeletal Pain (470)  ·  Muscle Weakness (442)  ·  Chronic Pain (352)  ·  Myofascial Pain Syndromes (321)  ·  Tennis Elbow (288)  ·  Fatigue Syndrome, Chronic (260)  ·  Stroke (254)  ·  Motor Activity (234)  ·  Muscular Dystrophies (222)  ·  Tendinopathy (219)

Broader conditions

Musculoskeletal Diseases (6447)  ·  Nervous System Diseases (4411)  ·  Pathological Conditions, Signs and Symptoms (3191)  ·  Neuromuscular Diseases (3163)  ·  Signs and Symptoms (2845)  ·  Neurologic Manifestations (2727)  ·  Rheumatic Diseases (1422)  ·  Neuromuscular Manifestations (1184)  ·  Joint Diseases (1029)  ·  Pain (1014)  ·  Pathologic Processes (1010)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (996)  ·  Genetic Diseases, Inborn (929)  ·  Muscular Disorders, Atrophic (818)

Interventions

Exercise (159)  ·  Botulinum Toxins, Type A (102)  ·  Dry Needling (95)  ·  Physical Therapy Modalities (67)  ·  Extracorporeal Shockwave Therapy (58)  ·  Sodium Chloride (56)  ·  Pregabalin (52)  ·  Control Groups (48)  ·  Lidocaine (45)  ·  Resistance Training (45)  ·  Transcutaneous Electric Nerve Stimulation (43)  ·  Exercise Therapy (42)  ·  Low-Level Light Therapy (40)  ·  Therapeutics (37)  ·  Musculoskeletal Manipulations (36)

Sponsors

Cairo University (88)  ·  Riphah International University (84)  ·  Hacettepe University (66)  ·  Assistance Publique - Hôpitaux de Paris (45)  ·  Sarepta Therapeutics, Inc. (38)  ·  University of Florida (37)  ·  Copenhagen University Hospital, Rigshospitalet (31)  ·  University of Sao Paulo (30)  ·  Massachusetts General Hospital (28)  ·  Stanford University (28)  ·  VA Office of Research and Development (28)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (27)  ·  Assiut University (25)  ·  Karolinska Institutet (25)  ·  Marmara University (25)

Countries

United States (1935)  ·  Turkey (Türkiye) (821)  ·  Spain (561)  ·  France (441)  ·  United Kingdom (354)  ·  Canada (340)  ·  Italy (317)  ·  Germany (264)  ·  Brazil (228)  ·  China (201)  ·  Egypt (198)  ·  Denmark (191)  ·  Belgium (180)  ·  Netherlands (179)  ·  Pakistan (164)

Top investigators

Wolnei Caumo, PhD (8)  ·  Michio Hirano, MD (6)  ·  Nicholas Johnson, MD (6)  ·  Roland Staud, MD (6)  ·  Akiko Okifuji, PhD (5)

Results publications

PMID 34590307, PMID 20461783, PMID 24482784, PMID 41766528, PMID 22588748, PMID 26694975, PMID 31284771, PMID 36526263, PMID 36583575, PMID 38059274, PMID 39400109, PMID 11871683, PMID 1298767, PMID 15928561, PMID 21039311, PMID 21639874, PMID 22503162, PMID 25386668, PMID 25408141, PMID 26212172, PMID 27149465, PMID 27288517, PMID 30171341, PMID 32594264, PMID 32956407, PMID 34099238, PMID 37539981, PMID 37957586, PMID 41671094, PMID 42613652, PMID 10826123, PMID 11149662, PMID 11514085, PMID 11869609, PMID 12091180, PMID 12401454, PMID 12472328, PMID 1593914, PMID 17370477, PMID 18018993, PMID 18075402, PMID 18311814, PMID 18395479, PMID 18804003, PMID 19446324, PMID 19554094, PMID 20046132, PMID 20236839, PMID 20358216, PMID 20406506

NIH funding

2023 (29), 2019 (17), 2025 (17), 2015 (13), 2014 (12), 2018 (12), 2016 (11), 2017 (9), 2009 (5), U54NS078059 (5), 2008 (4), 2004 (3), U54NS048843 (3), 2005 (2), P01HD032062 (2)